Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin

Hitoshi Honda1, Melissa J Krauss, Craig M Coopersmith

  • 1Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri 63110, USA. hhonda@im.wustl.edu

Abstract

Insights

Patients colonized with Staphylococcus aureus (S. aureus) in the ICU face a higher risk of developing S. aureus infections. Methicillin-resistant S. aureus (MRSA) colonization significantly increases this risk, even after accounting for other patient factors.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Staphylococcus aureus is a frequent cause of infection in intensive care unit (ICU) patients.
  • Colonization with methicillin-resistant S. aureus (MRSA) is a known risk factor for subsequent S. aureus infection.
  • MRSA-colonized patients may have more comorbidities, potentially increasing susceptibility to infection.

Purpose of the Study:

  • To investigate if MRSA-colonized ICU patients are more prone to developing S. aureus infections compared to MSSA-colonized or non-colonized patients.
  • To determine this risk independently of other patient risk factors.

Main Methods:

  • Prospective cohort study conducted in medical and surgical ICUs.
  • Nasal swab cultures for S. aureus performed on 9,523 patients at ICU admission.
  • ICU-acquired S. aureus infection defined as infection developing >48 hours post-admission.

Main Results:

  • S. aureus colonization was identified in 27.8% of patients (MRSA: 47.0%, MSSA: 53.0%).
  • ICU-acquired S. aureus infection occurred in 2.19% of patients, with MRSA being the causative agent in 66.4% of these cases.
  • MRSA colonization at admission (aHR, 4.70) and MSSA colonization (aHR, 2.47) were significant risk factors for ICU-acquired S. aureus infection.

Conclusions:

  • S. aureus colonization at ICU admission increases the risk of developing S. aureus infection during the ICU stay.
  • MRSA-colonized patients exhibit a significantly higher likelihood of developing S. aureus infection compared to MSSA-colonized or non-colonized patients, even after adjusting for patient-specific risk factors.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...